Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Crescita Therapeutics Inc (CTX.TO)

Crescita Therapeutics Inc (CTX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 8,655
  • Shares Outstanding, K 18,614
  • Annual Sales, $ 19,580 K
  • Annual Income, $ -2,750 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -0.06
  • Price/Sales 0.40
  • Price/Cash Flow 4.36
  • Price/Book 0.53
  • Price/Earnings ttm 23.25
  • Earnings Per Share ttm 0.02
  • Most Recent Earnings $0.04 on 11/05/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4000 +16.25%
on 11/25/25
0.4650 unch
on 12/23/25
+0.0050 (+1.09%)
since 11/20/25
3-Month
0.4000 +16.25%
on 11/25/25
0.5100 -8.82%
on 11/05/25
-0.0100 (-2.11%)
since 09/23/25
52-Week
0.4000 +16.25%
on 11/25/25
0.6100 -23.77%
on 12/27/24
-0.1250 (-21.19%)
since 12/23/24

Most Recent Stories

More News
Crescita Reports Third Quarter 2025 Results

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company,...

CTX.TO : 0.4650 (unch)
Crescita Reports Second Quarter 2025 Results

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company,...

CRRTF : 0.0210 (-93.28%)
CTX.TO : 0.4650 (unch)
Stocks in play: Crescita Therapeutics Inc.

Today reported its financial results for the first quarter ended March 31, 2025. Revenue was $3,537, ...

CTX.TO : 0.4650 (unch)
Stocks in play: Crescita Therapeutics Inc.

Will be presenting and participating in 1x1 meetings at the Planet MicroCap Showcase: VANCOUVER 2024 ...

CTX.TO : 0.4650 (unch)
Stocks in play: Crescita Therapeutics Inc.

Today announced that it has signed an exclusive Manufacturing and Supply Agreement with a leading Canadian ...

CTX.TO : 0.4650 (unch)
Stocks in play: Crescita Therapeutics Inc.

Reported its financial results for the second quarter ended June 30, 2023. Revenue was $5.1 million, ...

CTX.TO : 0.4650 (unch)
Crescita Reports Q4 and Fiscal 2022 Results

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“ Crescita ” or the “ Company ”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial...

CRRTF : 0.0210 (-93.28%)
OTC.VN : 0.620 (-3.13%)
CTX.TO : 0.4650 (unch)
Crescita Reports Third Quarter 2022 Results

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial...

CRRTF : 0.0210 (-93.28%)
OTC.VN : 0.620 (-3.13%)
CTX.TO : 0.4650 (unch)
Crescita Reports Second Quarter 2022 Results

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial...

CRRTF : 0.0210 (-93.28%)
OTC.VN : 0.620 (-3.13%)
CTX.TO : 0.4650 (unch)
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the voting results...

CRRTF : 0.0210 (-93.28%)
OTC.VN : 0.620 (-3.13%)
CTX.TO : 0.4650 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Crescita Therapeutics Inc is a commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery...

See More

Key Turning Points

3rd Resistance Point 0.4783
2nd Resistance Point 0.4717
1st Resistance Point 0.4683
Last Price 0.4650
1st Support Level 0.4583
2nd Support Level 0.4517
3rd Support Level 0.4483

See More

52-Week High 0.6100
Fibonacci 61.8% 0.5298
Fibonacci 50% 0.5050
Fibonacci 38.2% 0.4802
Last Price 0.4650
52-Week Low 0.4000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar